Keizman, D.; Frenkel, M.; Peer, A.; Rosenbaum, E.; Sarid, D.; Leibovitch, I.; Mano, R.; Yossepowitch, O.; Wolf, I.; Geva, R.;
et al. Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study. Nutrients 2023, 15, 3533.
https://doi.org/10.3390/nu15163533
AMA Style
Keizman D, Frenkel M, Peer A, Rosenbaum E, Sarid D, Leibovitch I, Mano R, Yossepowitch O, Wolf I, Geva R,
et al. Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study. Nutrients. 2023; 15(16):3533.
https://doi.org/10.3390/nu15163533
Chicago/Turabian Style
Keizman, Daniel, Moshe Frenkel, Avivit Peer, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, Ido Wolf, Ravit Geva,
and et al. 2023. "Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study" Nutrients 15, no. 16: 3533.
https://doi.org/10.3390/nu15163533
APA Style
Keizman, D., Frenkel, M., Peer, A., Rosenbaum, E., Sarid, D., Leibovitch, I., Mano, R., Yossepowitch, O., Wolf, I., Geva, R., Margel, D., Rouvinov, K., Stern, A., Dresler, H., Kushnir, I., & Eliaz, I.
(2023). Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study. Nutrients, 15(16), 3533.
https://doi.org/10.3390/nu15163533
